Multani Pratik S
Insider CIK 1586894 · CMRX Director · FATE Chief Medical Officer · RXDX Chief Medical Officer · ERAS Director · ORIC Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ERAS Erasca, Inc. | A Award deriv | 2026-06-26 | 2026-06-29 | 29,888 | — | $0 | 29,888 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 35,500 | — | $0 | 35,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 214,000 | — | $0 | 214,000 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2026-01-01 | 2026-01-05 | 19,532 | — | $0 | 19,532 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2025-12-16 | 2025-12-17 | 10,720 | $9.06 | $97.1K | 68,149 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-12-15 | 2025-12-17 | 11,333 | — | $0 | 22,667 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-12-15 | 2025-12-17 | 8,000 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-12-15 | 2025-12-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2025-12-15 | 2025-12-17 | 29,333 | — | $0 | 78,869 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2025-06-24 | 2025-06-26 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ERAS Erasca, Inc. | G Gift | 2025-05-23 | 2025-06-03 | 6,200 | — | $0 | 166,666 | SEC↗ |
| ERAS Erasca, Inc. | G Gift | 2025-05-23 | 2025-06-03 | 6,200 | — | $0 | 6,200 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 50,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 60,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 35,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 60,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 60,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 35,000 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 202,500 | — | $0 | 202,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 34,000 | — | $0 | 34,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2024-12-16 | 2024-12-17 | 8,850 | $8.28 | $73.3K | 46,765 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-15 | 2024-12-17 | 10,000 | — | $0 | 20,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-15 | 2024-12-17 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-15 | 2024-12-17 | 6,042 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2024-12-15 | 2024-12-17 | 24,042 | — | $0 | 55,615 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2024-06-20 | 2024-06-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2024-01-02 | 2024-01-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2024-01-02 | 2024-01-03 | 180,000 | — | $0 | 180,000 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2024-01-01 | 2024-01-03 | 32,867 | — | $0 | 32,867 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2023-12-15 | 2023-12-19 | 8,000 | — | $0 | 16,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2023-12-15 | 2023-12-19 | 6,042 | — | $0 | 6,042 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2023-12-15 | 2023-12-19 | 5,282 | $8.59 | $45.4K | 23,809 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2023-12-15 | 2023-12-19 | 14,042 | — | $0 | 29,091 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2023-06-22 | 2023-06-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2023-06-09 | 2023-06-12 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2023-02-01 | 2023-02-02 | 145,000 | — | $0 | 145,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2023-02-01 | 2023-02-02 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2022-12-15 | 2023-02-17 | 2,227 | $3.07 | $6.8K | 7,285 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2022-12-15 | 2022-12-16 | 6,041 | — | $0 | 12,084 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2022-12-15 | 2022-12-16 | 6,041 | — | $0 | 9,512 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2022-12-15 | 2022-12-16 | 2,089 | $3.25 | $6.8K | 7,423 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | D To issuer deriv | 2022-07-20 | 2022-07-21 | 90,000 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | D To issuer deriv | 2022-07-20 | 2022-07-21 | 147,500 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | D To issuer deriv | 2022-07-20 | 2022-07-21 | 108,750 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-07-20 | 2022-07-21 | 147,500 | — | $0 | 147,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-07-20 | 2022-07-21 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-07-20 | 2022-07-21 | 108,750 | — | $0 | 108,750 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2022-06-23 | 2022-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-02-01 | 2022-02-02 | 18,125 | — | $0 | 18,125 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-02-01 | 2022-02-02 | 108,750 | — | $0 | 108,750 | SEC↗ |
| ERAS Erasca, Inc. | P Buy | 2021-07-20 | 2021-07-20 | 6,200 | $16.00 | $99.2K | 172,866 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2021-06-23 | 2021-06-25 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2021-02-01 | 2021-02-02 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2020-06-11 | 2020-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2020-04-23 | 2020-04-27 | 147,500 | — | $0 | 147,500 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2020-02-21 | 2020-02-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RXDX Ignyta, Inc. | D To issuer deriv | 2018-02-08 | 2018-02-12 | 50,000 | — | $0 | 0 | SEC↗ |
| RXDX Ignyta, Inc. | D To issuer deriv | 2018-02-08 | 2018-02-12 | 200,000 | — | $0 | 0 | SEC↗ |
| RXDX Ignyta, Inc. | D To issuer | 2018-02-08 | 2018-02-12 | 74,134 | $27.00 | $2.00M | 0 | SEC↗ |
| RXDX Ignyta, Inc. | A Award | 2018-01-05 | 2018-01-05 | 4,400 | — | $0 | 74,134 | SEC↗ |
| RXDX Ignyta, Inc. | A Award | 2017-12-22 | 2017-12-22 | 23,334 | — | $0 | 69,734 | SEC↗ |
| RXDX Ignyta, Inc. | A Award deriv | 2017-01-05 | 2017-01-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RXDX Ignyta, Inc. | A Award | 2016-01-07 | 2016-01-11 | 26,400 | — | $0 | 46,400 | SEC↗ |
| RXDX Ignyta, Inc. | A Award deriv | 2015-02-17 | 2015-02-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RXDX Ignyta, Inc. | A Award | 2015-02-17 | 2015-02-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2015-01-05 | 2015-01-07 | 70,000 | — | $0 | 70,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2015-01-05 | 2015-01-07 | 3,024 | — | $0 | 3,024 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2014-01-09 | 2014-01-10 | 85,000 | — | $0 | 85,000 | SEC↗ |